000 01538nas a22003135i 4500
001 1179-6901
003 DE-He213
005 20260610082454.0
007 cr nn 008mamaa
008 150723s||||||||sz uu poo|||||| b|EN |d
022 _a1179-6901
024 7 _a10.1007/40268.1179-6901
_2doi
210 1 0 _aDrugs R D
245 1 0 _aDrugs in R&D
_h[electronic resource] /
_cedited by Anton van Rensburg.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Adis.
300 _bonline resource.
520 _aDrugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy. The Journal includes: Preclinical (in vitro and in vivo) research of direct relevance to clinical drug development Negative/neutral study data Studies on discontinued drugs/indications Drug stability studies Bioequivalence and biosimilar studies .
650 0 _aTherapeutics.
650 0 _aPharmacology.
650 0 _aInternal medicine.
650 1 4 _aTherapeutics.
650 2 4 _aPharmacology.
650 2 4 _aInternal Medicine.
700 1 _avan Rensburg, Anton.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
776 0 8 _iPrinted version:
_x1174-5886
856 4 0 _uhttps://doi.org/10.1007/40268.1179-6901
_zOpen Access
999 _c1820
_d1820